Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

de Leon Maria; Cardenas Horacio; Vieth Edyta; Emerson Robert; Segar Matthew; Liu Yunlong; Nephew Kenneth; Matei Daniela

首页> 外文期刊>Gynecologic Oncology: An International Journal >Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

【24h】

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

机译：跨膜蛋白88（TMEM88）启动子低甲基化与卵巢癌的铂耐药相关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives. Epigenetic alterations have been implicated in the development of platinum resistance in ovarian cancer (OC). In this study, we aimed to identify DNA methylation changes in platinum resistant tumors and their functional implications.

机译：目标。表观遗传学改变与卵巢癌（OC）的铂耐药性发展有关。在这项研究中，我们旨在确定铂耐药性肿瘤中的DNA甲基化变化及其功能含义。

著录项

来源
《Gynecologic Oncology: An International Journal》 |2016年第3期|共9页
作者
de Leon Maria; Cardenas Horacio; Vieth Edyta; Emerson Robert; Segar Matthew; Liu Yunlong; Nephew Kenneth; Matei Daniela;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Ovarian cancer; DNA methylation; Cisplatin resistance; TMEM88; Wnt;

机译：卵巢癌DNA甲基化顺铂耐药TMEM88 Wnt;

相似文献

外文文献
中文文献
专利

1. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer [J] . de Leon Maria, Cardenas Horacio, Vieth Edyta, Gynecologic Oncology: An International Journal . 2016,第3期

机译：跨膜蛋白88（TMEM88）启动子低甲基化与卵巢癌的铂耐药相关
2. Differential activation of NF-kappa B signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells [J] . Gaikwad Snehal M., Thakur Bhushan, Sakpal Asmita, The international journal of biochemistry and cell biology . 2015,第Null期

机译：NF-κB信号的差异激活与MyD88缺乏的上皮性卵巢癌细胞中的铂和紫杉烷抗性相关
3. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines [J] . Yan XD, Pan LY, Yuan Y, Journal of proteome research . 2007,第2期

机译：通过蛋白质组学分析人类卵巢癌细胞及其抗铂亚型，鉴定抗铂相关蛋白
4. Tensor decomposition-based unsupervised feature extraction for integrated analysis of TCGA data on microRNA expression and promoter methylation of genes in ovarian cancer [C] . Y-h. Taguchi, Ka-Lok Ng IEEE International Conference on Bioinformatics and Bioengineering . 2018

机译：基于张量分解的无预测特征提取，用于卵巢癌中基因TCGA数据综合分析及卵巢癌基因的促进剂甲基化
5. A 3’UTR KRAS-variant as a Biomarker of Poor Outcome and Platinum Chemotherapy Resistance in Ovarian Cancer [D] . Keane, Florence Kathleen 2011

机译：3’UTR KRAS变异作为卵巢癌预后不良和铂类化疗耐药的生物标志物
6. Transmembrane Protein 88 (TMEM88) Promoter Hypomethylation is Associated with Platinum Resistance in Ovarian Cancer [O] . Maria de Leon, Horacio Cardenas, Edyta Vieth, -1

机译：跨膜蛋白88（TMEM88）启动子的低甲基化与卵巢癌的铂耐药相关。
7. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer [O] . Maria de Leon, Horacio Cardenas, Edyta Vieth, 2016

机译：跨膜蛋白88（TMEM88）启动子低甲基化与卵巢癌中的铂抗性有关
8. Multimodal Theragnostic Anticancer Complexes of Rhenium to Circumvent Platinum Resistance in Relapsed Ovarian Cancer. [R] . Wilson, J. J. 2018

机译：多模式诊断抗癌复合物的铼与复发卵巢癌的环境铂电阻。

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

摘要

著录项

相似文献

相关主题

期刊订阅